title: A closer look at papillary thyroid carcinoma.
abstract: Recent surge of thyroid cancer, especially papillary thyroid carcinoma (PTC), ignited a debate on over-diagnosis of cancer. Such increase in incidence is a worldwide phenomenon, but it has been the most prominent in Korea. Although increased detection might have played a major role, some evidences suggest that true increase in incidence have also contributed to such phenomenon. PTC is a very common disease being the most common cancer in human. As the mortality due to PTC is relatively low, understanding pathophysiology of the disease and risk prediction in individual patient have particular importance for optimal management, but little has been known. I suggest a reason for such a commonality of PTC, and would like to describe my view on some aspects of PTC including unresolved issue on management based on our recent observations.
authors.affiliation: Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. kimwb@amc.seoul.kr.
authors.forename: Won Bae
authors.initials: WB
authors.lastname: Kim
keywords: Thyroid cancer, papillary; Thyroid neoplasms; Well differentiated thyroid carcinoma
references.citation: Cancer Res Treat. 2013 Mar;45(1):1-14
references.pmid: 23613665
references.citation: Thyroid. 2014 Apr;24(4):689-94
references.pmid: 24124924
references.citation: J Cancer Epidemiol. 2013;2013:965212
references.pmid: 23737785
references.citation: Endocrinol Metab (Seoul). 2014 Sep;29(3):217-25
references.pmid: 25309778
references.citation: Lancet. 2014 Jul 26;384(9940):319-28
references.pmid: 24768112
references.citation: Clin Endocrinol (Oxf). 2006 Sep;65(3):364-8
references.pmid: 16918957
references.citation: Endocrinol Metab (Seoul). 2015 Sep;30(3):305-11
references.pmid: 25433662
references.citation: J Clin Endocrinol Metab. 2010 Mar;95(3):1169-73
references.pmid: 20080852
references.citation: J Endocrinol Invest. 2012 Apr;35(4):413-8
references.pmid: 21897114
references.citation: Nat Rev Endocrinol. 2013 Mar;9(3):178-84
references.pmid: 23358352
references.citation: Cancer Discov. 2014 Aug;4(8):OF7
references.pmid: 25092762
references.citation: Nature. 2013 Jul 11;499(7457):214-8
references.pmid: 23770567
references.citation: J Clin Endocrinol Metab. 2011 Dec;96(12):3695-700
references.pmid: 21976723
references.citation: JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):317-22
references.pmid: 24557566
references.citation: Thyroid. 2012 Aug;22(8):784-90
references.pmid: 22780573
references.citation: Thyroid. 2013 Jan;23(1):58-63
references.pmid: 22973946
references.citation: J Endocrinol. 2009 Apr;201(1):161-7
references.pmid: 19168506
references.citation: Clin Endocrinol (Oxf). 2014 Oct;81(4):593-9
references.pmid: 24750108
references.citation: J Pediatr. 2014 Jun;164(6):1481-5
references.pmid: 24630354
references.citation: J Clin Endocrinol Metab. 2011 Jul;96(7):2049-56
references.pmid: 21508143
references.citation: Clin Endocrinol (Oxf). 2009 Oct;71(4):581-6
references.pmid: 19222495
references.citation: Thyroid. 2013 Aug;23(8):1015-21
references.pmid: 23360496
references.citation: J Clin Endocrinol Metab. 2008 Dec;93(12):4683-9
references.pmid: 18812478
references.citation: Eur J Endocrinol. 2013 May 03;168(6):879-86
references.pmid: 23513231
references.citation: Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1252-9
references.pmid: 23677575
references.citation: DNA Repair (Amst). 2013 Dec;12(12):1081-6
references.pmid: 24084170
references.citation: Endocr Relat Cancer. 2011 Dec 01;18(6):773-82
references.pmid: 22002574
references.citation: Cancer. 2009 Aug 15;115(16):3801-7
references.pmid: 19598221
references.citation: Eur J Endocrinol. 2013 Jan 17;168(2):219-25
references.pmid: 23161752